Scarica l'app Stockscreener
4.98
4.18%
0.20
Dopo l'orario di chiusura:
5.00
0.02
+0.40%
Precedente Chiudi:
$4.78
Aprire:
$4.77
Volume 24 ore:
79,870
Relative Volume:
0.01
Capitalizzazione di mercato:
$15.90M
Reddito:
-
Utile/perdita netta:
$-37.75M
Rapporto P/E:
-1.5323
EPS:
-3.25
Flusso di cassa netto:
$-30.91M
1 W Prestazione:
+6.18%
1M Prestazione:
-1.58%
6M Prestazione:
+1,647%
1 anno Prestazione:
+132.71%
Intervallo 1D:
$4.645
$5.02
Intervallo di 1 settimana:
$4.43
$5.08
Portata 52W:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Nome
Cellectar Biosciences Inc
Settore
Industria
Telefono
(608) 441-8120
Indirizzo
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Confronta CLRB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.98 | 15.39M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Ripresa | Ladenburg Thalmann | Buy |
| 2020-07-01 | Iniziato | Oppenheimer | Outperform |
| 2020-01-21 | Ripresa | ROTH Capital | Buy |
| 2019-09-13 | Iniziato | ROTH Capital | Buy |
| 2016-12-21 | Iniziato | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie
How to use a screener to detect Cellectar Biosciences Inc. breakouts2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
How moving averages guide Cellectar Biosciences Inc. trading2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Measuring Cellectar Biosciences Inc.’s beta against major indices2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
Cellectar Biosciences Announces Poster Presentation at AACR Conference on Preclinical Data for Novel Cancer Treatment CLR 121225 - Quiver Quantitative
Cellectar Biosciences Presents Data on CLR 121225 in Poster Presentation at AACR Special Conference on Pancreatic Cancer Research - AInvest
Cellectar Biosciences to Present Data in Poster - GlobeNewswire
Novel Pancreatic Cancer Radio-Conjugate: Cellectar to Present Breakthrough Treatment Data at AACR Conference - Stock Titan
Analyzing drawdowns of Cellectar Biosciences Inc. with statistical toolsJuly 2025 Levels & Reliable Momentum Entry Alerts - Newser
What indicators show strength in Cellectar Biosciences Inc.2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Identifying reversal signals in Cellectar Biosciences Inc.July 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Statistical indicators supporting Cellectar Biosciences Inc.’s strengthJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Cellectar Biosciences Inc. stock momentum explainedQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
What is Cellectar Biosciences Inc. s revenue forecast2025 Trading Volume Trends & Fast Moving Stock Trade Plans - khodrobank.com
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionTrade Ideas & Real-Time Price Movement Reports - Newser
Is Cellectar Biosciences Inc. trending in predictive chart modelsEarnings Beat & Weekly High Conviction Trade Ideas - Newser
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
Building trade automation scripts for Cellectar Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Is Cellectar Biosciences Inc. vulnerable to short sellers2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Using fundamentals and technicals on Cellectar Biosciences Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - The Ritz Herald
Is Cellectar Biosciences Inc. part of any ETF2025 Support & Resistance & Technical Pattern Recognition Alerts - khodrobank.com
Real time social sentiment graph for Cellectar Biosciences Inc.Market Weekly Review & Long-Term Safe Investment Plans - Newser
Earnings Recap: Is Cellectar Biosciences Inc. vulnerable to short sellersRate Hike & Target Return Focused Stock Picks - khodrobank.com
Is Cellectar Biosciences Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - khodrobank.com
Published on: 2025-09-01 21:25:14 - Newser
Does Cellectar Biosciences Inc. show high probability of reboundJuly 2025 Highlights & Low Risk Entry Point Tips - Newser
What is Cellectar Biosciences Inc. s debt to equity ratioQuarterly Market Review & AI Enhanced Trading Signals - خودرو بانک
Short interest data insights for Cellectar Biosciences Inc.Jobs Report & High Accuracy Swing Entry Alerts - Newser
Visualizing Cellectar Biosciences Inc. stock with heatmapsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Cellectar Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Certain Pre-Funded Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Certain Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Is it time to cut losses on Cellectar Biosciences Inc.Day Trade & Capital Protection Trade Alerts - Newser
Visual analytics tools that track Akoya Biosciences Inc. performanceJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
How to manage a losing position in Cellectar Biosciences Inc.Weekly Market Report & High Accuracy Investment Signals - Newser
How sentiment analysis helps forecast Cellectar Biosciences Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Cellectar Biosciences Inc. Consolidation Zone May Signal Accumulation getLinesFromResByArray error: size == 0 - newsyoung.net
Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cellectar Biosciences Inc Azioni (CLRB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):